Ascletis Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Ascletis Pharmaceuticals Co., Ltd., explained in plain language.
-
Acne drug faces final safety check in 240 patients
Disease control CompletedThis study checked the long-term safety of an experimental acne medication called ASC40 (Denifanstat) tablets. It involved 240 people with moderate to severe acne who had already completed a previous 12-week study. Participants took the pill once daily for up to 40 weeks while do…
Phase: PHASE3 • Sponsor: Ascletis Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New cancer pill enters human testing
Disease control CompletedThis early-stage trial tested a new oral medication called ASC61 in 18 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find the safest dose, see how the body processes the drug, and look for early signs that it might he…
Phase: PHASE1 • Sponsor: Ascletis Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC